Babanto, Alexa Mae B.
HRN: 23-96-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2024
AMPICILLIN 1GM (VIAL)
05/04/2024
05/11/2024
INTRAVENOUS
250 Mg IVTT
Every 6 Hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes